Compare IESC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IESC | BIO |
|---|---|---|
| Founded | 1997 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.2B |
| IPO Year | 1998 | N/A |
| Metric | IESC | BIO |
|---|---|---|
| Price | $404.36 | $302.01 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $358.50 |
| AVG Volume (30 Days) | ★ 162.7K | 158.3K |
| Earning Date | 02-03-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.87 | N/A |
| EPS | ★ 15.02 | N/A |
| Revenue | ★ $3,371,468,000.00 | $2,557,500,000.00 |
| Revenue This Year | $19.32 | $1.62 |
| Revenue Next Year | $15.14 | $2.26 |
| P/E Ratio | $27.06 | ★ N/A |
| Revenue Growth | ★ 16.89 | N/A |
| 52 Week Low | $146.52 | $211.43 |
| 52 Week High | $482.35 | $373.69 |
| Indicator | IESC | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 42.90 |
| Support Level | $401.12 | $298.78 |
| Resistance Level | $421.06 | $307.07 |
| Average True Range (ATR) | 21.32 | 7.77 |
| MACD | -5.92 | -0.97 |
| Stochastic Oscillator | 10.95 | 29.69 |
IES Holdings Inc owns and manages subsidiaries that design and installs integrated electrical and technology systems and provide infrastructure products and services. It has four business segments; Communications, Residential, Infrastructure Solutions, and Commercial & Industrial. The majority of the revenue for the company is generated from its Residential segment in which the company provides electrical installation services for single-family housing and multi-family apartment complexes, as well as heating, ventilation, and air conditioning (HVAC) and plumbing installation services. This segment also provides services for installing residential solar power, both for new construction and existing residences.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.